A Phase I Study to Assess the Safety and Immunogenicity of Novel Routes of Administration of Plasmodium Falciparum Malaria Vaccine Candidate ChAd63 Encoding ME-TRAP.
Phase of Trial: Phase I
Latest Information Update: 10 May 2017
At a glance
- Drugs Malaria DNA vaccine (Primary) ; Malaria DNA vaccine (Primary)
- Indications Malaria
- Focus Adverse reactions
- 05 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 05 May 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 05 May 2017 Status changed from not yet recruiting to recruiting.